Clinical Trials Logo

Clinical Trial Summary

A new male-specific dog-allergen-component has been found (Can f 5) which indicates possible differences in allergic reactions to male and female dogs. This has not yet been tested in real life. The aim is to test if sensitization only to the male-dog specific allergen-component, Can f 5, results in a positive skin prick test (SPT) to male dog extract and not female dog extract. In addition, the investigators want to investigate if allergic symptoms only occur when exposed to the male dog extract by conjunctival provocation.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03097094
Study type Interventional
Source Copenhagen Studies on Asthma in Childhood
Contact
Status Completed
Phase N/A
Start date March 24, 2017
Completion date January 9, 2019